Resultado de búsqueda
2022. Articles 1–20. Professor of Medicine, Director Dept of Haematology Peter MacCallum Cancer Centre & Royal Melbourne - Cited by 66,845 - Hematologic malignancies.
John Francis Seymour Jr. (born December 3, 1937) is an American retired politician who served as a United States senator from California from 1991 to 1992.
21 de mar. de 2018 · Anderson MA, Deng J, Seymour JF, et al. The BCL2 selective inhibitor venetoclax induces rapid onset apoptosis of CLL cells in patients via a TP53-independent mechanism. Blood 2016;127:3215-3224.
Professor John Seymour AM is a clinical haematologist and the Director of the Haematology Department of the Peter MacCallum Cancer Centre & the Royal Melbourne Hospital.
12 de dic. de 2018 · John F. Seymour, MBBS, PhD, clinical hematologist, associate director of Clinical Research, Peter MacCallum Centre, director of the integrated Haematology Department of the Peter MacCallum Cancer...
2 de nov. de 2023 · Key secondary objectives are to assess pharmacokinetics, pharmacodynamics (PD), and preliminary antitumor activity. Safety was assessed according to CTCAE v5.0 (all pts) and iwCLL hematologic toxicity criteria (pts with CLL). Dose-limiting toxicities (DLTs) were assessed in the first 4 weeks.
28 de mar. de 2024 · Casan and Seymour provide a state-of-the-art review of proteolysis-targeting chimeras (PROTACs), the leading class of targeted protein degradation agents.
